kotak-logo

Sumitomo Chemicals India Ltd (SCIL) Q4FY25 Earnings Update: What You Need to Know

  •  3 min read
  •  1,033
  • Published 18 Dec 2025
Sumitomo Chemicals India Ltd (SCIL) Q4FY25 Earnings Update: What You Need to Know

Sumitomo Chemicals India Ltd (SCIL) recently announced its Q4FY25 earnings report, providing a snapshot of its financial health and future outlook. Let’s break down the key points from the report and what it means for investors and the agrochemicals sector.

SCIL's Q4FY25 performance was below market expectations, primarily driven by a decline in exports. Despite this setback, the company demonstrated strong operational metrics for the full fiscal year.

This reflects a solid underlying business performance with healthy margins and volume growth, signaling operational efficiency and robust demand domestically.

Looking ahead to FY26, SCIL remains optimistic. The company expects:

  • Early monsoon onset – which benefits sowing activities

  • Stable commodity prices – aiding cost control

  • Increased sowing acreage – boosting product demand

These factors together are expected to create a favourable environment for growth in FY26.

There is a minor revision in earnings estimates for FY26 and FY27, with changes ranging from a slight decrease of 1% to a potential increase of 3%. Although SCIL trades at a premium compared to its peers, it is rated as a "Reduce" stock with a revised Fair Value (FV) of ₹495, slightly down from ₹485. The Current Market Price (CMP) stands at ₹510, indicating a modest downside risk for investors.

SCIL had several bright spots in Q4FY25 and FY25:

  • Strong volume growth: The company reported approximately 20% YoY growth in volumes in FY25.

  • Robust product pipeline: For FY26, SCIL has two patented high-potential molecules expected to drive future revenue.

  • Capital expenditure: The company announced two brownfield capex projects at Bhavnagar and Tarapur to support the parent company's global requirements, signaling long-term investment in capacity expansion.

On the downside, SCIL saw:

  • A 14.7% decline in EBITDA and a 9.2% decline in PAT (Profit After Tax) YoY in Q4FY25.

  • The agrochemicals sector faced de-rating due to macroeconomic concerns and adverse weather impacting demand.

  • Pricing pressures and channel inventory build-up also weighed on financial performance.

For clarity:

  • EBITDA (Earnings Before Interest, Tax, Depreciation & Amortisation) reflects core operational profitability.

  • PAT (Profit After Tax) is the actual net profit available to shareholders.

A decline in these metrics typically signals challenges in either sales volume, pricing, or increased costs.

Lightbox image

This simple bar chart illustrates the contrast between strong volume growth and declining profitability in Q4FY25.

Sumitomo Chemicals India Ltd delivered a mixed Q4FY25 performance with volume growth and strategic investments offset by export declines and sector-wide pressures. The company’s outlook for FY26 remains cautiously optimistic, backed by early monsoon and a strong product pipeline.

Investors should weigh the premium valuation against near-term earnings pressure and sector uncertainties. The recommendation is to "Reduce" with a revised Fair Value of ₹495, indicating modest downside risk from the current price.

Did you enjoy this article?

0 people liked this article.